chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Big welt on my arm; 7 days later in the area where she got the shot; doesn't feel good; feels generally like when you're kind of getting sick; rash; hot; hard; very itchy; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Big welt on my arm), PERIPHERAL SWELLING (7 days later in the area where she got the shot), RASH (rash), DRY SKIN (hot) and PAIN IN EXTREMITY (hard) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced RASH (rash), DRY SKIN (hot), PAIN IN EXTREMITY (hard) and PRURITUS (very itchy). On 09-Mar-2021, the patient experienced FEELING ABNORMAL (doesn't feel good) and FACTITIOUS DISORDER (feels generally like when you're kind of getting sick). On an unknown date, the patient experienced PERIPHERAL SWELLING (Big welt on my arm) and PERIPHERAL SWELLING (7 days later in the area where she got the shot). On 06-Mar-2021, RASH (rash), DRY SKIN (hot), PAIN IN EXTREMITY (hard) and PRURITUS (very itchy) outcome was unknown. At the time of the report, PERIPHERAL SWELLING (Big welt on my arm), PERIPHERAL SWELLING (7 days later in the area where she got the shot), FEELING ABNORMAL (doesn't feel good) and FACTITIOUS DISORDER (feels generally like when you're kind of getting sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Consent given for safety to contact patient. Corrective treatment was not provided   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: No new information was recieved
After 2nd rabies vaccination in R deltoid - pruritic, edematous area extending approximately 10 cm around anterior R arm, with some associated erythema, tenderness, poikilothermia.
Pt. called and said injection site was swollen, hot and red. Sore arm.
Loss of appetite/changes in eating habits; pain at the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of DECREASED APPETITE (Loss of appetite/changes in eating habits) and VACCINATION SITE PAIN (pain at the injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C21A and 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Allergy to antibiotic (Erythromycin) and Drug allergy (Morphine). Concomitant products included IBUPROFEN and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-May-2021, the patient experienced DECREASED APPETITE (Loss of appetite/changes in eating habits) and VACCINATION SITE PAIN (pain at the injection site). At the time of the report, DECREASED APPETITE (Loss of appetite/changes in eating habits) and VACCINATION SITE PAIN (pain at the injection site) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-133164 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Follow up received on 18-JUN-2021, Events outcome were updated from Unknown to Recovered.
chills; congestion; achiness; runny nose; pain around the sinuses; fever; cough; tired; low appetite; sneezing; headache; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on 18Jan2021 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient developed symptoms 11 days after her first dose. On 29Jan2021, she reported Chills, Congestion, Achiness, Runny nose, Pain around the Sinuses, Fever, Cough, Tired, Low appetite, Sneezing and Headache. The patient wanted to know if these side effects were reported with Pfizer Covid-19 vaccine. The patient also asked if she can I still develop COVID-19 infection after receiving the first dose. Also, if the vaccine cause a false positive COVID-19 test. She also asked what was the timing of the 2nd dose of vaccine and if she can get the second dose 21 days after dose 1. The patient also asked if both doses of Pfizer COVID-19 vaccine are identical. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
About 3 days after the 2nd dose,  I started to feel chest pressure like a muscle pull on the chest. About 7 days after the vaccine, it started to worsen.  I felt pain, chest pressure, back shoulder pain,  jaw pain,  and shortness of breath.   I called the main local  hospital number and was instructed to go to the ER.  I did go to the ER and they did blood work, EKG which confirmed that I was having a heart attack.  I was stabilized and was then transferred my via ambulance to A Medical Center which is bigger hospital and better equipped.  I was admitted and the next day, I had surgery for a heart catheter. They also placed 2 stents in my heart.   I was in the hospital for 4 days and was discharged with a prescription for Furosemide 40mg, rest, cardiac rehab, and to follow up with cardiologist.  Prior to the heart attack, I only had hypertension.
I started having lower back pain within hours of the 2nd shot, along with major headache, exhaustion By that night I had chills, exhaustion, back pain Since then, my back has been in spasm. Extremely, extremely painful spasm The pain is not movement related. I am fine while sleeping and generally while walking. Sitting or standing still brings on the pain
Initial and follow-up information has been received from a registered nurse and a physician concerning a 66 year old female with penicillin allergy and allergies to LIPITOR, PRAVACOL, TRILEPTAL, and a history of hives with niacin and no illness at the time of vaccination who on 15-FEB-2007 was vaccinated intramuscularly in the right deltoid with a 0.5 ml first dose of Pneumovax 230(lot 655152/0889F). The patient was concomitantly vaccinated with a second dose of Fluzone (lot U2202AA). Concomitant therapy included ACIPHEX, aspirin, vitamin B (unspecified), vitamin B complex, ubidecarenone, CRESTOR, omega-3 marine triglycerides, glucosamine, LAMICTAL, NEXIUM and ezetimibe. On 15-FEB-2007, in the evening, the patient had extreme pain in the arm in which Pneumovax 23 was administered. The entire area from the right elbow to the shoulder/ upper arm was in pain. The patient had difficulty moving the right arm. The injection site was fine. The patient received the flu vaccine in the left arm which was not painful. The patient was still having pain the week following the vaccination. The patient was seen at an urgent care center. An x-ray done of right shoulder was normal. The patient was treated with PERCOCET, NAPROSYN, and ibuprofen and ice. The patient then switched therapy from PERCOCET to  VICODIN. The patient saw her primary care physician on 21-FEB-2007 with ongoing shoulder pain. The patient was referred to sports and orthopedic medicine. The outcome was unknown. The patient's right shoulder pain was considered an other important medical event. No additional information is expected.
Started having the chills, feeling feverish, muscle aches, lost taste and smell, headache, fatigue, running nose diarrhea and had loss of appetite.
achy muscles; joint pain; fever; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th April 2021, the patient received the 1st dose of Shingrix. On 6th April 2021, less than a week after receiving Shingrix, the patient experienced muscle pain, joint pain and fever. On an unknown date, the outcome of the muscle pain, joint pain and fever were not recovered/not resolved.   It was unknown if the reporter considered the muscle pain, joint pain and fever to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient had achy muscles, joint pain and fever, which was not yet resolved till the time of reporting. The patient did not consent to follow up.
Chills; 101 temperature; This is a spontaneous report from a contactable consumer.  A 74-year-old male patient received second dose of BNT162B2 (solution for injection; (Batch/Lot Number: EL9266) via an unspecified route of administration in right arm on 20Feb2021 at 16:00 as single dose for covid-19 immunization. The patient medical history not reported. Historical vaccine included BNT162B2 (Dose number: 1; lot number=EL8982; administration date=28Jan2021; administration time=04:00 PM; vaccine location= Right arm) and concomitant medications were not reported. On 21Feb2021, the patient experienced chills and 101 body temperature. Treatment was not received for the events. The patient underwent lab tests and procedures which included body temperature 101. The outcome of the events was not recovered.
Breakthrough case admission after 3 vaccines Pfizer 4/3/21 lot# Ew0150;  Pfizer 4/24/21 lot# ER8729;  Pfizer 10/30/21 lot# 30145BA
did not seroconvert; patient suffered a broken nose/nasal valve collapse which led to bronchitis and is now considered chronic bronchitis; patient suffered a broken nose/nasal valve collapse which led to bronchitis and is now considered chronic bronchitis; This spontaneous report was received from a physician via company representative referring to a 21 year old male patient (reporter's son). Information about patient's concurrent condition, drug allergy/reaction, medical history, concomitant medication was not reported.   On an unknown date, the patient was vaccinated with haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) (strength, dose, dose number, route, anatomical location, lot/batch #, expiry date was not reported) for prophylaxis (reported as hemophilus influenzae protection).  On an unknown date, the patient did not seroconvert from vaccination (seroconversion test negative) (found with titer test). On an unknown date (reported as in the last 4 years/ within the last 4 years), the patient experienced a broken nose/nasal valve collapse which lead to bronchitis which was now considered as chronic bronchitis nasal valve collapse and bronchitis chronic. The patient sought medical attention by visiting office.The outcome of seroconversion test negative, bronchitis chronic and nasal valve collapse was unknown. The reporter's causality assessment was reported.
Father and Son came in together about 45 min earlier than their appointment.  They were in a rush  when checking in for the appointment.   They came to the check-in table and we went over the consent form and made sure we saw that the patients date of birth was in the year of 2003.  However, after the vaccination was given at the point of data entry we realized that the patient is not actually 18 years old till a month later.  We called and were sent directly to voicemail and we left a message to call us back.  And no call back has been received.
Developed slight bleeding from rectum in 2/2021, had Colonoscopy, removal of polyp, and biopsy , results were negative for Cancer Findings: Internal Hemmorhoids. Being treated for Internal Hemmorhoids, bleeding continued had another  Colonoscopy in 9/13/22, findings was Rectal Cancer Stage 4 with Metastases to Liver.  Rectal mass was 7.45 cm circumferential mass, there were 5 liver masses measuring 4.7 x 3.2, 3.7  x 3.4, etc.  liver masses doubled in size from 9/13/22-11/09/22,  rectal mass shrank in half after  multiple IV chemos , liver masses maintained sizes, CEA level was not improving.  Latest CT scans of Chest, Abfomen, Pelvis 0n 3/23/2023 showed the liver masses increased in size, multiple additional swollen nodules,  and lungs shows glass like opacities in apical and bases in both lungs.
diverticulosis; sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) and DIVERTICULUM (diverticulosis) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE for Hypothyroidism.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). On an unknown date, the patient experienced DIVERTICULUM (diverticulosis). At the time of the report, OROPHARYNGEAL PAIN (sore throat) had not resolved and DIVERTICULUM (diverticulosis) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included salt water gargle.  Sore throat is reported to be caused by pollution and other environmental factors.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up received - Outcome of the event sore throat updated, causality was updated and new event diverticulosis added.
Bruise on vaccination site. Red rash and swelling at vaccination site appeared 1 week after vaccination. Nausea, vomiting since vaccination. All side effects still present over 1 week after vaccination date.
Patient received his 1st COVID (Pfizer) vaccine and he bled more than usual. Patient reported feeling faint and nauseous. While monitoring patient, he threw up a few minutes later. He felt better shortly after. We kept in the pharmacy area for observation for 30 minutes to ensure that he was ok before he left. Patient was feeling fine when he finally left.
her arm was more sore right now than in her first shot.; This is a spontaneous report from a contactable consumer (patient) reported for herself. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: number was not reported) dose 2 on 07Jun2021 via an unspecified route of administration for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: number was not reported) dose 1 on unspecified date via an unspecified route of administration for covid-19 immunisation and had sore arm. The patient said on an unspecified date in Jun2021, her arm was more sore right now than in her first shot. The patient had the second shot of the Pfizer COVID-19 vaccine yesterday (07Jun2021) and she wanted to know why she was reacting differently than when she had her first shot. Outcome of the event was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Experiencing numbness; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Experiencing numbness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Experiencing numbness). At the time of the report, HYPOAESTHESIA (Experiencing numbness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported Treatment medication information were not reported   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow up document received on 14-Jun-2021 provides no new information.
Reaction started on 2.27 mid-morning- she began having a sensation in the back of her neck. Rash began on the nap of neck- swollen bumps.  traveled around the front of the neck and then cheeks and eyes.  Continued near tear ducks and all-around eye. Both eyes began to swell on 2.28 and she went to the ED for treatment.  They gave her a steroid shot and benadryl IM. Discharged home, with no medications, but instructed to take benadryl as needed. She is taking benadryl every 6-8 hours for itching.   She is not fully recovered due to itching and continued rash.  Follow up appointment with PCP the end of this week begin of next.
Dermatographia flareups started occurring on about 12/26/21 -- itchiness in different parts of body, with red splotches that appear and disappear within the span of about 30 minutes
PATIENT EXPERIENCED SWEATING, AND DIZZINESS FOLLOWING VACCINE ADMINISTRATION.  TEMPERATURE WAS 98.8, SYMPTOMS PERSISTED FOR 15 MINUTES.  PATIENT FANNED,  COLD COMPRESSION APPLIED, AND GIVEN WATER. PATIENT SEEKED EMERGENCY TREATMENT.
Bells Palsy; This is a spontaneous report from a contactable Other HCP (patient).   A 63-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Lot # EL1284) intramuscular at single dose at left arm on 29Dec2020 16:30 for Covid-19 immunisation, administered at hospital.  Medical history included hypertension, thyroid disorder, high cholesterol, fibromyalgia, allergy to sulfur drugs and codeine. The patient was not pregnant. The patient had not experienced Covid-19 prior vaccination. The patient previously took codeine and experienced drug hypersensitivity. The patient had not received any other vaccines within 4 weeks prior to the BNT162B2 vaccine.  The patient experienced bells palsy on 11Jan2021. The event resulted in Emergency room/department or urgent care. The event bells palsy has been treated with steroids. Post vaccination, the patient has been not tested for COVID-19. The outcome of event was recovering.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of bells palsy cannot be excluded, considering the plausible temporal relationship. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate
Had normal reaction to vaccine after the second dose: Fever, severe bone pain, chills, fatique for 48 h. After 3 months of the second dose, started pain in small joints especially thumbs and forefingers. Pain has increased since and other joints are affected too including wrist, elbow, knees and toes. Pain in hands is severe enough to affect writing and normal daya to day activity.
Large black and blue and purple area on site of injection (about 8 x 4"). Painful. Began evening of injection. Referred to clinic for evaluation.
Information has been received from a physician assistant (PA) concerning a female patient who in "early" December 2006, was vaccinated with the first dose of HPV (yeast). The PA reported that the patient "did not have any symptoms except" what the PA stated was "normal pain at the moment of injection." The patient sought unspecified medical attention.
area, faded red color; first 3-31-2021, never received second; shingles, buttocks, back and thigh; mild pinpoint itching; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 31st March 2021, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, the patient received the 2nd dose of Shingrix. On 13th January 2022, 288 days after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles and pruritus. On an unknown date, the patient experienced skin red and incomplete course of vaccination. On an unknown date, the outcome of the shingles was recovered/resolved and the outcome of the skin red and incomplete course of vaccination were unknown and the outcome of the pruritus was not recovered/not resolved.   It was unknown if the reporter considered the shingles, skin red and pruritus to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient. The patient received 1st dose of Shingrix in an unknown arm. The patient did not receive 2nd dose of Shingrix within recommended time interval because he forgot about it, which led to incomplete course of vaccination. The patient stated that, after vaccination with 1st dose, shingles appeared on his left buttocks and back upper left thigh, the shingles appear to have cleared up and the area where the shingles were a faded red color, no bumps. The patient reported that, occasionally felt a mild pinpoint itching that only lasts a few seconds. The reporter did not consent to follow up.
Patient presented the day after being given vaccines with fever , irritability and bulging fontanelle . Patient was admitted to Hospital for observation. CBC , blood culture and urine studies were normal. LP was attempted and failed . Ultrafast brain MRI was normal except for incidental arachnoid cyst - 11 mm  in size.  Patient defervesced without additional treatment and was discharged in stable condition after 24 hrs.
I started vomiting severely on 12/22/2021 and on 12/23/2021 I started having diarrhea and I am still in the midst of it.
T103-104.9 w/in 24 hrs of receiving vax-no other sym rx APAP; dress lightly urge fluids;
Severe headache, sore throat, weakness, fever (5 days), antibiotic prescribed at urgen care (6 days). Severe dizziness, ataxia, weakness (Imetrex shot). Worsened #2 symptoms; sent to first emergency room; tests determine brain stem encephalitis; referred to large hospital. Second MRI due to double vision/facial numbness. ADEM encephalitis. The hospital discharge summary states sinusitis and hypokalemia. The hospital hischarge summary states numbness, nausea, and vomiting.  60-day follow up on 11/26/2003: "Vaccine recipient did not recover from the adverse events that were reported for this vaccination.  Continues to experience headaches, fatigue, short term memory problems and leg weakness. Not returned to full time work.  6 month MRI scheduled for 12/15.  Lesions were still evident in June."
Fever lasting more  than 48 hours, extreme fatigue, nausea, light headedness, pain at injection site, profuse sweating.
Developed severe jaw pain bilaterally, Seemed to be trigeminal neuralgia. 8/10 pain. Lasted at least 90 minutes. Took Ibuprofen 400mg and Tylenol 650 just prior to the pain beginning due to myalgias with previous immunizations of Covid. Stayed on nonsteroidals for 60 hours with no recurrence Day 5 around 5pm developed facial paresthesia, dizziness and fatigue with slow onset. Normal daily activity and patterns. Took 400mg Ibuprofen with resolution of symptoms
Had pain in left leg the night of the vaccine. On Friday the 16th, I started having numbness and tingling in my left leg and arm. Now I am also having mild left-sided facial numbness.